Skip to main content
Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
34.87
+1.28 (3.81%)
At close: Apr 28, 2026, 4:00 PM EDT
34.69
-0.18 (-0.52%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Sutro Biopharma Revenue

In the year 2025, Sutro Biopharma had annual revenue of $102.48M with 65.18% growth. Sutro Biopharma had revenue of $11.65M in the quarter ending December 31, 2025, a decrease of -21.35%.

Revenue (ttm)
$102.48M
Revenue Growth
+65.18%
P/S Ratio
5.78
Revenue / Employee
$748,058
Employees
137
Market Cap
577.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025102.48M40.44M65.18%
Dec 31, 202462.04M-91.69M-59.64%
Dec 31, 2023153.73M85.96M126.84%
Dec 31, 202267.77M5.89M9.52%
Dec 31, 202161.88M19.16M44.84%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Rigel Pharmaceuticals 294.28M
Prothena Corporation 9.68M
Ocugen 4.41M
Altimmune 41.00K
Lyell Immunopharma 36.00K
Revenue Rankings

STRO News

More News